AMRN Q4 2022 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M-37.5% YoY

Gross Profit

$64M70.5% margin

Operating Income

-$10M-10.6% margin

Net Income

$856,0000.9% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+0.4%

Cash Flow

Operating Cash Flow

-$205,201

Free Cash Flow

-$205,200

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$886M

Total Liabilities

$291M

Stockholders' Equity

$595M

Cash & Equivalents

$218M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$144M	-37.5%
Gross Profit	$64M	$114M	-44.1%
Operating Income	-$10M	$16M	-159.4%
Net Income	$856,000	$15M	-94.2%

Revenue Segments

Product

$90M99%

Licensing And Royalty

$738,0001%